Breaking News Instant updates and real-time market news.

P

Pandora

$8.95

-0.52 (-5.49%)

, SIRI

SiriusXM

$5.86

0.05 (0.86%)

17:10
07/31/17
07/31
17:10
07/31/17
17:10

Pandora: Financial future 'secure' after SiriusXM investment

Pandora (P) says its financial future is "secure" after SiriusXM (SIRI) investment. Says "encouraged" that decline in active users in Q2 was lower than decline in Q1. Says seeing stronger than expected user engagement. Says will do more to arrest decline in users. Comments taken from Q2 earnings conference call.

P

Pandora

$8.95

-0.52 (-5.49%)

SIRI

SiriusXM

$5.86

0.05 (0.86%)

  • 31

    Jul

  • 08

    Aug

  • 09

    Aug

  • 05

    Sep

P Pandora
$8.95

-0.52 (-5.49%)

07/24/17
RHCO
07/24/17
NO CHANGE
RHCO
Pandora to focus on 'core radio moentization,' says SunTrust
After meeting with Pandora's interim CEO, SunTrust analyst Matthew Thornton says that the company plans to focus on further moentizing its core i.e. free radio offering. The analyst says that the company plans to increase the size of its sales force, a move that he believes could raise its "revenue/EBITDA" by $150M. Thornton adds that the company intends to expand to overseas markets over the longer term. He keeps a $10.50 price target and a Buy rating on the shares.
07/05/17
07/05/17
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Pandora (P) resumed with an Overweight at Morgan Stanley. 2. Two Harbors (TWO) reinstated with an Outperform at Credit Suisse. 3. Alcentra Capital (ABDC) initiated with a Buy at DA Davidson. 4. Alon USA Partners (ALDW) reinstated with an Equal Weight at Barclays. 5. Delek US (DK) and Delek Logistics (DKL) were reinstated with an Equal Weight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/05/17
MSCO
07/05/17
INITIATION
Target $12
MSCO
Overweight
Pandora resumed with an Overweight at Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne resumed coverage on Pandora with an Overweight and a $12 price target. The analyst said the Sirius/Liberty investment improves the balance sheet but the core radio business supports a $12 price target.
06/26/17
06/26/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Coach (COH) upgraded to Buy from Neutral by Buckingham analyst Scott Krasik, who sees further upside based on expectations core margins can expand, Kate Spade accretion will exceed expectations, and thinks the company will make further additive acquisitions over the next few years. 2. Costco (COST) upgraded to Outperform from Market Perform by Raymond James analyst Budd Bugatch, who noted that the shares have pulled back approximately 13% since June 15 in reaction to Amazon's (AMZN) purchase of Whole Foods (WFM), which he views as providing a buying opportunity. 3. Pandora (P) upgraded to Sector Weight from Underweight at Pacific Crest by analyst Andy Hargreaves, who said the SiriusXM-appointed board members are likely to push for a moderated cash burn rate. The analyst believes lower cash burn, even at the expense of subscriber growth, would be a positive for Pandora. 4. UBS (UBS) upgraded to Overweight from Neutral by JPMorgan analyst Kian Abouhossein, who views the current valuation as attractive. 5. Goldman analyst Michael Lapides upgraded Duke Energy (DUK) to Buy and raised its price target to $85 from $82 saying relative valuation is compelling. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
SIRI SiriusXM
$5.86

0.05 (0.86%)

06/26/17
FBRC
06/26/17
NO CHANGE
Target $11
FBRC
Outperform
Pandora added to Alpha Generator list at FBR Capital
FBR Capital analyst Barton Crockett added Pandora Media to his firm's Alpha Generator list and keeps an Outperform rating on the shares with an $11 price target. The analyst sees a favorable setup for the shares with SiriusXM (SIRI) gaining three board seats. New management improves Pandora's ad-based opportunity while cost cutting potential limits downside risks, Crockett tells investors in a research note.
06/26/17
PACS
06/26/17
UPGRADE
PACS
Sector Weight
Pandora upgraded to Sector Weight from Underweight at Pacific Crest
Pacific Crest analyst Andy Hargreaves upgraded Pandora Media (P) to Sector Weight saying the SiriusXM-appointed board members are likely to push for a moderated cash burn rate. The analyst believes lower cash burn, even at the expense of subscriber growth, would be a positive for Pandora. He has a $6 fair value estimate for the shares.
06/23/17
JPMS
06/23/17
NO CHANGE
Target $14
JPMS
Overweight
Pandora selloff since SiriusXM investment overdone, says JPMorgan
JPMorgan analyst Doug Anmuth acknowledged that his Overweight rating on Pandora (P) shares "has been wrong" so far. He lowered his 2018 EBITDA forecast and cut his price target on the shares to $14 from $18. However, he believes Pandora now has a strong strategic partner in SiriusXM (SIRI) and expects its operational focus to shift back to the ad-supported digital radio market. He keeps an Overweight rating on the stock and believes the 7% drop since the news of Sirius' investment has been overdone.
06/12/17
RHCO
06/12/17
NO CHANGE
RHCO
Deal/news has mixed implications for Pandora, says SunTrust
After Pandora (P) announced a $480M investment by Sirius (SIRI), SunTrust analyst Matthew Thornton says that Sirius' presence on Pandora's board will have a positive impact on the latter company. He adds that the new capital should enable Pandora to increase its investments in key areas, However, on the negative side, he notes that Pandora wasn;t sold, while the reported $8 per share offer for Pandora by Sirius, if true, is "unsettling." Additionally, the analyst thinks that a number of Pandora's top shareholders could exit the stock in the wake of the news. However, he keeps a $10.50 per share price target and a Buy rating on Pandora.

TODAY'S FREE FLY STORIES

KSU

Kansas City Southern

$105.80

-0.07 (-0.07%)

17:45
08/18/17
08/18
17:45
08/18/17
17:45
Hot Stocks
Kansas City Southern director Henry Maier buys 3,000 shares »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

RXII

RXi Pharmaceuticals

$0.58

-0.02 (-3.36%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on RXi Pharmaceuticals »

RXi Pharmaceuticals files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WIN

Windstream

$1.98

0.06 (3.13%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Hot Stocks
Windstream CEO acquires 25,381 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$2.44

-0.22 (-8.27%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on CEL-SCI »

CEL-SCI files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRN

Trinity Industries

$28.20

-0.03 (-0.11%)

17:25
08/18/17
08/18
17:25
08/18/17
17:25
Hot Stocks
ValueAct raises stake inTrinity Industries to 11% from 9.8% »

As of this date, ValueAct…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPTN

Lpath

17:11
08/18/17
08/18
17:11
08/18/17
17:11
Hot Stocks
Breaking Hot Stocks news story on Lpath »

Stonepine Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGR

Progressive

$48.63

0.12 (0.25%)

17:08
08/18/17
08/18
17:08
08/18/17
17:08
Hot Stocks
Progressive CFO sells 50,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$172.57

-0.32 (-0.19%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Thermo Fisher director sells 11,318 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

SMBC

Southern Missouri Bancorp

$31.18

-0.05 (-0.16%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Southern Missouri Bancorp and Southern Missouri Bancshares to merge »

Southern Missouri Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:58
08/18/17
08/18
16:58
08/18/17
16:58
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ended advisory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says never had…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:56
08/18/17
08/18
16:56
08/18/17
16:56
Hot Stocks
Icahn no longer special advisor to President Trump on regulatory reform issues »

Carl Icahn, founder of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:55
08/18/17
08/18
16:55
08/18/17
16:55
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:49
08/18/17
08/18
16:49
08/18/17
16:49
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$30.38

0.76 (2.57%)

16:48
08/18/17
08/18
16:48
08/18/17
16:48
Hot Stocks
Micron director sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 06

    Sep

INSY

Insys Therapeutics

$9.17

-0.11 (-1.19%)

16:42
08/18/17
08/18
16:42
08/18/17
16:42
Hot Stocks
Insys agrees to pay $4.45M to settle opioid marketing suit »

Illinois Attorney General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTX

Akari Therapeutics

16:34
08/18/17
08/18
16:34
08/18/17
16:34
Syndicate
Breaking Syndicate news story on Akari Therapeutics »

Akari Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JMBA

Jamba

$9.11

-0.04 (-0.44%)

16:32
08/18/17
08/18
16:32
08/18/17
16:32
Hot Stocks
Jamba receives expected letter from Nasdaq »

Jamba, Inc. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIL

Hill International

$4.50

0.2 (4.65%)

16:31
08/18/17
08/18
16:31
08/18/17
16:31
Hot Stocks
Hill International receives NYSE notice regarding late Form 10-Q filing »

Hill International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$55.65

-0.47 (-0.84%)

16:30
08/18/17
08/18
16:30
08/18/17
16:30
Periodicals
Target ends relationship with food startup Hampton Creek, Bloomberg says »

After an internal review,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
08/18/17
08/18
16:30
08/18/17
16:30
Options
Preliminary option volume of 23.2M today »

Preliminary option volume…

NBEV

New Age Beverages

$3.51

-0.49 (-12.25%)

16:29
08/18/17
08/18
16:29
08/18/17
16:29
Hot Stocks
New Age Beverages director sells nearly 42,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ATW

Atwood Oceanics

$6.26

0.22 (3.64%)

, ESV

Ensco

$4.28

0.12 (2.88%)

16:24
08/18/17
08/18
16:24
08/18/17
16:24
Hot Stocks
Atwood Oceanics, Ensco file proxy materials in connection with pending merger »

Ensco (ESV) and Atwood…

ATW

Atwood Oceanics

$6.26

0.22 (3.64%)

ESV

Ensco

$4.28

0.12 (2.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$83.76

-0.1 (-0.12%)

16:23
08/18/17
08/18
16:23
08/18/17
16:23
Periodicals
Nestle faces potential fraud suit over Poland Spring marketing, WSJ says »

Nestle is facing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.